Schedule 13D ownership disclosure

Actinium Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 00507W107

Event date: 2015-12-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-15-002854
Form type
SC 13D/A
Filer
Actinium Pharmaceuticals, Inc.
CIK
CIK 1388320
Filed
Dec 23, 2015
Reporting period
Dec 21, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub